Coronary Microvascular Dysfunction: PET, CMR and CT Assessment
- PMID: 33922841
- PMCID: PMC8123021
- DOI: 10.3390/jcm10091848
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment
Abstract
Microvascular dysfunction is responsible for chest pain in various kinds of patients, including those with obstructive coronary artery disease and persistent symptoms despite revascularization, or those with myocardial disease without coronary stenosis. Its diagnosis can be performed with an advanced imaging technique such as positron emission tomography, which represents the gold standard for diagnosing microvascular abnormalities. In recent years, cardiovascular magnetic resonance and cardiac computed tomography have demonstrated to be emerging modalities for microcirculation assessment. The identification of microvascular disease represents a fundamental step in the characterization of patients with chest pain and no epicardial coronary disease: its identification is important to manage medical strategies and improve prognosis. The present overview summarizes the main techniques and current evidence of these advanced imaging strategies in assessing microvascular dysfunction and, if present, their relationship with invasive evaluation.
Keywords: angina; cardiac computer tomography; cardiac magnetic resonance; microvascular dysfunction; positron emission tomography.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Maron D.J., Hochman J.S., Reynolds H.R., Bangalore S., O’Brien S.M., Boden W.E., Chaitman B.R., Senior R., López-Sendón J., Alexander K.P., et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N. Engl. J. Med. 2020;382:1395–1407. doi: 10.1056/NEJMoa1915922. - DOI - PMC - PubMed
-
- Lu D.Y., Yalcin H., Yalcin F., Zhao M., Sivalokanathan S., Valenta I., Tahari A., Pomper M.G., Abraham T.P., Schindler T.H., et al. Stress Myocardial Blood Flow Heterogeneity is a Positron Emission Tomography Biomarjer of Ventricular Arrythmias in Patients with Hypertrophic Cardiomyopathy. Am. J. Cardiol. 2018;121:1081–1089. doi: 10.1016/j.amjcard.2018.01.022. - DOI - PMC - PubMed
-
- Neglia D., Michelassi C., Trivieri M.G., Sambuceti G., Giorgetti A., Pratali L., Gallopin M., Salvadori P., Sorace O., Carpeggiani C., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186–193. doi: 10.1161/hc0202.102119. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
